CLINICAL_TRIALS trial_result · 2015-08-04

Clinical Trial Update: Study of AERAS-402 in Healthy Infants [Phase 1, Phase 2]

AERAS-402, a tuberculosis vaccine candidate, was tested in healthy infants in Phase 1/Phase 2, with the study completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Aeras | Conditions: Tuberculosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-08-04